{"title":"Abbott Laboratories†","authors":"","doi":"10.1002/div.7606","DOIUrl":null,"url":null,"abstract":"<p><b>Pharmaceuticals (MIC: SIC: 2834 NAIC: 325412)</b></p><p>Abbott Laboratories is principally engaged in the discovery, development, manufacture and sale of a variety of health care products through four business segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Co.'s primary products are prescription Pharmaceuticals, nutritional products, vascular products and diagnostic testing products. In addition, Co. has a 50.0%-owned joint-venture, TAP Pharmaceutical Products Inc. with Takeda Pharmaceutical Company Ltd. of Japan, through which Co. develops, markets and sells pharmaceutical products such as Lupron<sup>®</sup>, Lupron Depot<sup>®</sup> and Prevacid<sup>®</sup> (lansoprazole), within the U.S., Puerto Rico and Canada.</p>","PeriodicalId":100917,"journal":{"name":"Mergent's Dividend Achievers","volume":"5 4","pages":"1"},"PeriodicalIF":0.0000,"publicationDate":"2008-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/div.7606","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Mergent's Dividend Achievers","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/div.7606","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Pharmaceuticals (MIC: SIC: 2834 NAIC: 325412)
Abbott Laboratories is principally engaged in the discovery, development, manufacture and sale of a variety of health care products through four business segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products. Co.'s primary products are prescription Pharmaceuticals, nutritional products, vascular products and diagnostic testing products. In addition, Co. has a 50.0%-owned joint-venture, TAP Pharmaceutical Products Inc. with Takeda Pharmaceutical Company Ltd. of Japan, through which Co. develops, markets and sells pharmaceutical products such as Lupron®, Lupron Depot® and Prevacid® (lansoprazole), within the U.S., Puerto Rico and Canada.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
